115 Results for "

CRC

" in MedChemExpress (MCE) Product Catalog:
Products (115)

115 Results for "CRC" in MCE Product Catalog:

Cat. No.: HY-162285
Target:  

Akt

Research Areas:  

Cancer

Anticancer agent 189 (compound 4) is an anticancer agent that antagonizes CRC effects by targeting AKT1 .
loading...
    loading...
Cat. No.: HY-170306
CAS No.: 844441-29-8
Target:  

CDK

Research Areas:  

Cancer

LZ9 is a ATP-competitive CDK1 and CDK2 inhibitor. LZ9 has the potential for the research of colorectal cancer (CRC) .
loading...
    loading...
Cat. No.: HY-N11777
CAS No.: 1205676-02-3
Synonyms: NHAP
(−)-N-Hydroxyapiosporamide (NHAP), an alkaloid, is an NF-κB inhibitor with potent antitumor activity in vitro and in vivo. (−)-N-Hydroxyapiosporamide can be used for the research of colorectal cancer (CRC) .
loading...
    loading...
Cat. No.: HY-153214
CAS No.: 2131223-92-0
Purity:  99.48%
Target:  

Wnt β-catenin

Research Areas:  

Cancer

YW2036 (compound 2a) is a potent Wnt/β-Catenin signaling pathway inhibitor with an IC50 value of 637 nM. YW2036 can be used in research of colorectal cancer (CRC) .
loading...
    loading...
Cat. No.: HY-169652
CAS No.: 864860-32-2
Research Areas:  

Cancer

NPC26 is a small molecule mitochondrial disruptor with anti-tumor activity. NPC-26 shows significant anti-proliferative and cytotoxic effects on CRC cell lines (HCT-116, DLD-1, and HT-29). NPC26 can damage mitochondrial function, leading to the opening of the mitochondrial permeability transition pore (mPTP) and the production of reactive oxygen species, ultimately inducing cell death. NPC-26 can kill CRC cells by activating the AMP-activated protein kinase (AMPK) signaling pathway .
loading...
    loading...
Cat. No.: HY-162516
CAS No.: 2939087-00-8
Research Areas:  

Cancer

DBI-2 is an AMPK activator targeting mitochondrial complex I. DBI-2 disrupts the OXPHOS process, and reduces ATP generation in mitochondria. DBI-2 inhibits the proliferation of colorectal cancer (CRC) cells .
loading...
    loading...
Cat. No.: HY-172537
CAS No.: 3034091-87-4
Target:  

DNA/RNA Synthesis

Research Areas:  

Inflammation/Immunology Cancer

Indolimine-214 is a metabolite of M. morganii Indolimine-214 increases the level of γH2AX in HeLa cells. Indolimine-214 can be used in the study of inflammatory bowel disease (IBD) and colorectal cancer (CRC) .
loading...
    loading...
Cat. No.: HY-Y0106R
CAS No.: 699-83-2
2,6-Dihydroxyacetophenone (Standard) is the analytical standard of 2,6-Dihydroxyacetophenone (HY-Y0106). This product is intended for research and analytical applications. 2,6-Dihydroxyacetophenone, a polyphenolic derivative of Acetophenone (HY-Y0989), is an orally active mTOR inhibitor. 2,6-Dihydroxyacetophenone shows antioxidant activity. 2,6-Dihydroxyacetophenone inhibits cell growth and proliferation in CRC cells. 2,6-Dihydroxyacetophenone arrests at G0/G1 phase of cell cycle, induces apoptosis and suppresses cell migration in CRC cells. 2,6-Dihydroxyacetophenone inhibits xanthine oxidase (XOD) with an IC50 of 1.24 mM. 2,6-dihydroxyacetophenone improves uric acid metabolism in hyperuricemia mice, reduces plasma cholesterol in hypercholesterolemic rats, and inhibits lipid accumulation in HFD-induced obese mice. 2,6-Dihydroxyacetophenone can be used for the study of colorectal cancer (CRC), hyperuricemia and hypercholesterolemia .
loading...
    loading...
Cat. No.: HY-160493
CAS No.: 1219439-82-3
Target:  

Wnt β-catenin

Research Areas:  

Cancer

PTK7/β-catenin-IN-6 (Compound 03653) is an inhibitor for PTK7/β-catenin interaction, which inhibits the Wnt signaling pathway, and exhibits an anticancer activity against colorectal cancer (CRC) .
loading...
    loading...
Cat. No.: HY-119261
CAS No.: 80214-88-6
Target:  

Antibiotic

Research Areas:  

Cancer

Ruboxyl is an anthracycline antibiotic with antitumor activity. Ruboxyl inhibits colorectal cancer (CRC) liver metastasis in mice by 84%, suppresses B16 melanoma growth, and increases the survival rate of mice with L1210 or L5178Y leukemia .
loading...
    loading...
Cat. No.: HY-B0008A
CAS No.: 63804-15-9
Synonyms: MK-231 sodium
Target:  

NF-κB PD-1/PD-L1

Sulindac (MK-231) is an orally active nonsteroidal anti-inflammatory agent. Sulindac also is an immunomodulatory agent. Sulindac can be used for the research of arthritis of the spine, gouty arthritis and kinds of cancer including colorectal cancer (CRC) and lung cancer .
loading...
    loading...
Cat. No.: HY-161826
Target:  

Wnt β-catenin HSP CDK c-Myc

Research Areas:  

Cancer

Antitumor agent-174 (Compound 10) directly engages the N-terminal site of Hsp90 and promotes the degradation of β-catenin, thereby suppressing the Wnt/β-catenin signaling. Antitumor agent-174 effectively inhibits proliferation, induce S and G2/M phases arrest and block the clonogenic ability in CRC cells. Antitumor agent-174 down-regulates CDK1, Cyclin D1, c-Myc, Cyclin B1, and Cyclin A2, and upregulaties P21 proteins. Antitumor agent-174 has significant anti-tumor efficacy against colorectal cancer (CRC) with excellent pharmacokinetics and low toxicity .
loading...
    loading...
Cat. No.: HY-162148
CAS No.: 1980848-48-3
Target:  

EGFR

Research Areas:  

Cancer

HNPMI is an inhibitor of EGFR and has cytotoxic effects on tumor cells. HNPMI can downregulate the protein levels of osteopontin, survivin and cathepsin S, leading to apoptosis. HNPMI also regulates BCL-2/BAX and p53 in CRC cell lines to inhibit tumorigenesis .
loading...
    loading...
Cat. No.: HY-161102
Target:  

Autophagy

Research Areas:  

Cancer

[Ru(phen)2(xant)] hexafluorophosphate is an inducer of Autophagy. [Ru(phen)2(xant)] hexafluorophosphate eliminates CRC stem cells by targeting the chaperone Hsp90. [Ru(phen)2(xant)] hexafluorophosphate reduces cell migration and invasion .
loading...
    loading...
Cat. No.: HY-146254
CAS No.: 2414598-85-7
hCAIX-IN-12 is a potent hCAIX inhibitor with IC50 values of 0.74, 10.78 μM for CAIX and CAII, respectively. hCAIX-IN-12 shows antiproliferative effect and induces apoptosis. hCAIX-IN-12 increases ROS production. hCAIX-IN-12 has the potential for the research of colorectal cancer (CRC) .
loading...
    loading...
Cat. No.: HY-122347
CAS No.: 579475-18-6
Synonyms: GW823296
Target:  

Neurokinin Receptor

Research Areas:  

Neurological Disease Cancer

Orvepitant (GW823296) is potent, selective, orally active and well-tolerated neurokinin-1 receptor (NK-1) antagonist with a pKi of 10.2 for human neurokinin-1 receptor. Orvepitant can across the blood-brain barrier. Orvepitant has the potential for depressive disorder and chronic refractory cough (CRC) treatment .
loading...
    loading...
Cat. No.: HY-163090
CAS No.: 3038691-79-8
Research Areas:  

Cancer

HR488B is an efficient HDAC1 inhibitor. HR488B specifically suppressed the growth of CRC cells by inducing cell cycle G0/G1 arrest and apoptosis. HR488B causes mitochondrial dysfunction, reactive oxygen species (ROS) generation, and DNA damage accumulation .
loading...
    loading...
Cat. No.: HY-B0008R
CAS No.: 38194-50-2
Synonyms: MK-231 (Standard)
Sulindac (Standard) is the analytical standard of Sulindac. This product is intended for research and analytical applications. Sulindac (MK-231) is an orally active nonsteroidal anti-inflammatory agent. Sulindac also is an immunomodulatory agent. Sulindac can be used for the research of arthritis of the spine, gouty arthritis and kinds of cancer including colorectal cancer (CRC) and lung cancer .
loading...
    loading...
Cat. No.: HY-108695BR
CAS No.: 77756-22-0
(±)-Enterodiol (Standard) is the analytical standard of (±)-Enterodiol. This product is intended for research and analytical applications. (±)-Enterodiol is the racemate of Enterodiol (HY-108695). Enterodiol is transformed by human intestinal bacteria from lignans contained in various whole-grain cereals, nuts, legumes, flaxseed, and vegetables. Enterodiol has an apoptotic effect in colorectal cancer (CRC) cells. Enterodiol has anti-cancer activities .
loading...
    loading...
Cat. No.: HY-161970
CAS No.: 1461652-87-8
Target:  

Topoisomerase Apoptosis

Research Areas:  

Cancer

XSJ05 is a camptothecin (CPT) derivative that can inhibit topoisomerase I (Topo I) to exert anti-cancer activity. XSJ05 can trigger DNA double-strand breaks, leading to DNA damage. XSJ05 can inhibit the growth of colorectal cancer (CRC), arrest the cell cycle in G2/M phase, and induce apoptosis .
loading...
    loading...